GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MPT
Medical Properties Trust, Inc.
There isn't enough reported data to score MPT yet.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
MPT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MPT's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MPT.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
MPT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.2x | $1.71 | — |
| Cheap | 7.1x | $2.90 | +70% |
| Fair | 22x | $8.96 | +424% |
| Expensive | 26x | $10.48 | +513% |
Historical ranges are pointers, not guarantees.
MPT has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
GS has the edge over MPT on the outlook, with more favorable earnings and revenue expectations.
MPT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect MPT's earnings and profitability to decline, with its revenue holding steady.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over MPT on earnings, with more consistent year-over-year improvement.
MPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.41 | +$1.58 |
| Q2 2026 | -$0.06 | +$2.32 |
| Q1 2026 | -$0.21 | +$2.55 |
| Q4 2025 | -$0.46 | +$3.56 |
| Q3 2025 | -$1.17 | +$3.28 |
| Q2 2025 | -$2.38 | +$0.54 |
| Q1 2025 | -$2.76 | -$0.31 |
| Q4 2024 | -$4.02 | -$3.08 |
MPT has returned to profit: it earned $0.41 per share over the past year, after losing money the year before.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over MPT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over MPT on profitability, with a higher operating margin.
MPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $250.1M | +5.3% |
| Q2 2026 | $259.3M | +7.9% |
| Q1 2026 | $252.1M | +13% |
| Q4 2025 | $270.3M | +17% |
| Q3 2025 | $237.5M | +5.2% |
| Q2 2025 | $240.4M | -9.8% |
| Q1 2025 | $223.8M | -18% |
| Q3 2024 | $225.8M | -26% |
MPT's revenue is recovering but still below its 2022 peak: $250M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.5% | -1.9 points |
| Q2 2026 | 3.3% | +0.5 points |
| Q1 2026 | 2.7% | +5.2 points |
| Q4 2025 | 14% | +1.8 points |
| Q3 2025 | -3.6% | +53 points |
| Q2 2025 | 2.9% | -4.6 points |
| Q1 2025 | -2.5% | -21 points |
| Q4 2024 | 12% | N/A |
MPT's operating margin was −5.5% last quarter, down 1.9 points from the same quarter a year ago, near the bottom of its range since 2019.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
MPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.1M | +122% |
| Q2 2026 | $62.4M | +21% |
| Q1 2026 | -$14.3M | -3813% |
| Q4 2025 | $160.1M | +109% |
| Q3 2025 | $18.6M | -69% |
| Q2 2025 | $51.7M | +47% |
| Q1 2025 | $384K | -99% |
| Q4 2024 | $76.7M | -43% |
MPT has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over MPT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
MPT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -799K shares |
| 1 year | -0.7% | -4M shares |
| 3 years | -0.2% | -1.4M shares |
| 5 years | 0% | -158K shares |
| Available history | +21% | +102M shares |
MPT has 597M diluted shares, down 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2023 | $2M |
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over MPT on leverage, with a lower net debt burden relative to earnings.
MPT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 27.0x | High |
| Q2 2026 | 28.8x | High |
| Q1 2026 | 29.0x | High |
| Q4 2025 | 30.7x | High |
| Q3 2025 | 32.3x | High |
| Q2 2025 | 30.0x | High |
| Q1 2025 | 24.9x | High |
| Q4 2024 | 20.3x | High |
MPT's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MPT.
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
MPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 14.7 | Oversold |
| Stochastic | 2.8 | Oversold |
MPT's weekly RSI is 15 (oversold) and its Stochastic is 3 (oversold).
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
MPT PE vs Financial Services Sector
| Metric | MPT | Sector median | Relative |
|---|---|---|---|
| PE | 4.2x | 13x | 68% below |
| PE % | 0 | 63 | 63 pts below |
MPT has the edge over GS on valuation relative to its sector.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS has the edge over MPT on trend strength, trading above more of its moving averages.
MPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 36% below |
| 20 week MA | $3.65 | 53% below |
| 50 week MA | $4.51 | 62% below |
| 100 week MA | $4.68 | 63% below |
| 200 week MA | $5.44 | 69% below |
MPT is in a downtrend: it's below all five of its weekly moving averages, and 69% below its 200-week average.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over MPT on returns for 2026, with the stronger performance.
MPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.7 | $21.7 | +4.9% |
| 2021 | $21.7 | $22.7 | +4.3% |
| 2022 | $22.7 | $11.2 | -51% |
| 2023 | $11.2 | $4.91 | -56% |
| 2024 | $4.91 | $3.73 | -24% |
| 2025 | $3.73 | $5.08 | +36% |
| 2026 YTD | $5.08 | $1.71 | -66% |
MPT has finished lower in three of the last six years. It's down 66% so far in 2026.